The estimated Net Worth of Duncan Gallagher is at least $328 Thousand dollars as of 18 August 2022. Mr. Gallagher owns over 15,000 units of Health Catalyst Inc stock worth over $281,470 and over the last 4 years he sold HCAT stock worth over $0. In addition, he makes $46,454 as Independent Director at Health Catalyst Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Gallagher HCAT stock SEC Form 4 insiders trading
Duncan has made over 1 trades of the Health Catalyst Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 15,000 units of HCAT stock worth $174,900 on 18 August 2022.
The largest trade he's ever made was buying 15,000 units of Health Catalyst Inc stock on 18 August 2022 worth over $174,900. On average, Duncan trades about 2,143 units every 0 days since 2020. As of 18 August 2022 he still owns at least 35,405 units of Health Catalyst Inc stock.
You can see the complete history of Mr. Gallagher stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Duncan Gallagher biography
Duncan Gallagher serves as Independent Director of the Company. Mr. Gallagher has served as a member of our board of directors since 2017. Since March 2017, Mr. Gallagher has served as President of Donegal Advisory Services, a healthcare consulting company. From August 2009 to January 2017, Mr. Gallagher held various positions at Allina Health, a healthcare services company, including Chief Financial Officer and Chief Administrative Officer. He currently serves on the board of directors of Carium, Inc., a privately-held healthcare technology company. Mr. Gallagher holds a B.S. from the University of South Dakota and an M.B.A. from the University of Minnesota.
What is the salary of Duncan Gallagher?
As the Independent Director of Health Catalyst Inc, the total compensation of Duncan Gallagher at Health Catalyst Inc is $46,454. There are 11 executives at Health Catalyst Inc getting paid more, with Daniel Burton having the highest compensation of $3,519,720.
How old is Duncan Gallagher?
Duncan Gallagher is 60, he's been the Independent Director of Health Catalyst Inc since 2017. There are 2 older and 16 younger executives at Health Catalyst Inc. The oldest executive at Health Catalyst Inc is John Kane, 67, who is the Independent Director.
What's Duncan Gallagher's mailing address?
Duncan's mailing address filed with the SEC is C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN, UT, 84095.
Insiders trading at Health Catalyst Inc
Over the last 5 years, insiders at Health Catalyst Inc have traded over $32,461,176 worth of Health Catalyst Inc stock and bought 554,600 units worth $5,926,241 . The most active insiders traders include Daniel D. Burton, Mark B Templeton, and Paul Horstmeier. On average, Health Catalyst Inc executives and independent directors trade stock every 8 days with the average trade being worth of $135,905. The most recent stock trade was executed by Benjamin Landry on 6 September 2024, trading 2,466 units of HCAT stock currently worth $18,224.
What does Health Catalyst Inc do?
health catalyst is dedicated to enabling health care organizations to fundamentally improve care by building the most comprehensive and fully integrated suite of healthcare data warehousing and process improvement solutions available. health catalyst was formed by a group of healthcare veterans with vast data warehousing and quality improvement experience. our founders and executives collaborated for nearly a decade to revolutionize clinical process models using analytics. during development, they faced numerous hurdles in the quest to develop a data warehouse that could handle the complexities unique to healthcare data. after determining that the predominant approaches to data modeling weren’t effective for healthcare data, they discovered the solution, which is now known as the adaptive data architecture. using a late-binding bus architecture, catalyst’s adaptive data model is agile, flexible, and can be implemented in a matter of weeks compared to the months or years traditional app
What does Health Catalyst Inc's logo look like?
Complete history of Mr. Gallagher stock trades at Health Catalyst Inc
Health Catalyst Inc executives and stock owners
Health Catalyst Inc executives and other stock owners filed with the SEC include:
-
Daniel Burton,
Chief Executive Officer, Director -
Paul Horstmeier,
Chief Operating Officer -
J. Patrick Nelli,
Chief Financial Officer -
Daniel D. Burton,
CEO & Director -
Paul Horstmeier,
Chief Operating Officer -
J. Patrick Nelli Jr.,
Pres -
Daniel H. Orenstein,
Gen. Counsel & Sec. -
Linda Llewelyn,
Chief People Officer -
John Kane,
Independent Director -
Fraser Bullock,
Independent Chairman of the Board -
Michael Dixon,
Independent Director -
Duncan Gallagher,
Independent Director -
Todd Cozzens,
Independent Director -
Anita Pramoda,
Independent Director -
Timothy Ferris,
Director -
Adam Brown,
Senior Vice President - Investor Relations -
S. Dawn Smith,
Independent Director -
Julie Larson-Green,
Independent Director -
Daniel Orenstein,
General Counsel, Corporate Secretary -
Amanda Hundt,
Vice President - Corporate Communications -
Linda Llewelyn,
Chief People Officer -
Kyle J. Salyers,
Sr. VP of Corp. Devel. -
Jason Jones,
Chief Analytics & Data Science Officer and GM of Data & Analytics Platform -
Dave Ross,
Chief Technology Officer -
Trudy Sullivan,
Chief Communications and Diversity, Equity & Inclusion Officer -
Bryan Richard Hinton,
Chief Technology Officer -
Jason Alger,
Chief Accounting Officer -
Bryan Truman Hunt,
Chief Financial Officer -
Dale Sanders,
Chief Technology Officer -
Venture Partners Xi, Lp Nor...,
-
Us (Ttgp), Ltd.Scgf V Manag...,
-
Promod Haque,
10% owner -
Mark B Templeton,
-
Bryan Truman Hunt,
Chief Financial Officer -
Bryan Richard Hinton,
Chief Technology Officer -
Kevin Lee Freeman,
Chief Commercial Officer -
Jason Alger,
Chief Financial Officer -
Daniel Le Sueur,
Chief Operating Officer -
Anne Marie Bickmore,
COO and Chief Product Officer -
Benjamin Landry,
General Counsel